Literature DB >> 23222560

Molecular pathology of lymphoma.

S E Coupland1.   

Abstract

Ocular lymphomas can be divided into intraocular lymphomas and ocular adnexal lymphomas. The vitreoretinal lymphoma-usually a diffuse large B-cell lymphoma (DLBCL) of high-grade malignancy-is the most common lymphoid malignancy arising in the eye, while the extranodal marginal zone B-cell lymphoma (EMZL), an indolent often recurrent tumour, occurs most frequently in the ocular adnexal tissue. The two lymphoma subtypes differ significantly in their clinical presentation, subsequent course and outcome as well as in their underlying morphological, immunophenotypical and genetic features. The molecular processes involved in DLBCL and EMZL development are complex, and include chromosomal translocations, mutations caused by aberrant somatic hypermutation, sporadic somatic mutations, and copy number alterations, characterized by deletions and amplifications. These lead to alterations in particular signalling pathways, which in turn activate transcription factors, such as nuclear factor NF-κB. This review provides an overview of the histological features of DLBCL and EMZL, and discusses the current insights into the molecular mechanisms underlying the development of these tumours, when they occur systemically and particularly when they arise in ocular tissues.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23222560      PMCID: PMC3574248          DOI: 10.1038/eye.2012.247

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  79 in total

1.  A gene expression-based method to diagnose clinically distinct subgroups of diffuse large B cell lymphoma.

Authors:  George Wright; Bruce Tan; Andreas Rosenwald; Elaine H Hurt; Adrian Wiestner; Louis M Staudt
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-04       Impact factor: 11.205

2.  The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells.

Authors:  Ryan T Phan; Riccardo Dalla-Favera
Journal:  Nature       Date:  2004-12-02       Impact factor: 49.962

3.  Direct repression of prdm1 by Bcl-6 inhibits plasmacytic differentiation.

Authors:  Chainarong Tunyaplin; A L Shaffer; Cristina D Angelin-Duclos; Xin Yu; Louis M Staudt; Kathryn L Calame
Journal:  J Immunol       Date:  2004-07-15       Impact factor: 5.422

4.  Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray.

Authors:  Christine P Hans; Dennis D Weisenburger; Timothy C Greiner; Randy D Gascoyne; Jan Delabie; German Ott; H Konrad Müller-Hermelink; Elias Campo; Rita M Braziel; Elaine S Jaffe; Zenggang Pan; Pedro Farinha; Lynette M Smith; Brunangelo Falini; Alison H Banham; Andreas Rosenwald; Louis M Staudt; Joseph M Connors; James O Armitage; Wing C Chan
Journal:  Blood       Date:  2003-09-22       Impact factor: 22.113

5.  Maturation of the immune response in germinal centers.

Authors:  C Berek; A Berger; M Apel
Journal:  Cell       Date:  1991-12-20       Impact factor: 41.582

6.  The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma.

Authors:  Kerry J Savage; Stefano Monti; Jeffery L Kutok; Giorgio Cattoretti; Donna Neuberg; Laurence De Leval; Paul Kurtin; Paola Dal Cin; Christine Ladd; Friedrich Feuerhake; Ricardo C T Aguiar; Sigui Li; Gilles Salles; Francoise Berger; Wen Jing; Geraldine S Pinkus; Thomas Habermann; Riccardo Dalla-Favera; Nancy Lee Harris; Jon C Aster; Todd R Golub; Margaret A Shipp
Journal:  Blood       Date:  2003-08-21       Impact factor: 22.113

7.  Clinicopathologic analysis of ocular adnexal lymphomas: extranodal marginal zone b-cell lymphoma constitutes the vast majority of ocular lymphomas among Koreans and affects younger patients.

Authors:  Eun Yoon Cho; Jae Joon Han; Howe Jung Ree; Young Hyeh Ko; Yoon-koo Kang; Hyo Sook Ahn; Seung Do Ahn; Chan Jeoung Park; Jooryung Huh
Journal:  Am J Hematol       Date:  2003-06       Impact factor: 10.047

8.  Transcription-targeted DNA deamination by the AID antibody diversification enzyme.

Authors:  Jayanta Chaudhuri; Ming Tian; Chan Khuong; Katrin Chua; Eric Pinaud; Frederick W Alt
Journal:  Nature       Date:  2003-04-09       Impact factor: 49.962

9.  Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2).

Authors:  P Revy; T Muto; Y Levy; F Geissmann; A Plebani; O Sanal; N Catalan; M Forveille; R Dufourcq-Labelouse; A Gennery; I Tezcan; F Ersoy; H Kayserili; A G Ugazio; N Brousse; M Muramatsu; L D Notarangelo; K Kinoshita; T Honjo; A Fischer; A Durandy
Journal:  Cell       Date:  2000-09-01       Impact factor: 41.582

10.  BCL6 controls the expression of the B7-1/CD80 costimulatory receptor in germinal center B cells.

Authors:  Huifeng Niu; Giorgio Cattoretti; Riccardo Dalla-Favera
Journal:  J Exp Med       Date:  2003-07-14       Impact factor: 14.307

View more
  12 in total

1.  [Retinal manifestation in hematological diseases].

Authors:  M Rehak; N Feltgen; P Meier; P Wiedemann
Journal:  Ophthalmologe       Date:  2018-09       Impact factor: 1.059

Review 2.  Galectins as therapeutic targets for hematological malignancies: a hopeful sweetness.

Authors:  Camilo Pena; Leonardo Mirandola; Jose A Figueroa; Nattamol Hosiriluck; Natallia Suvorava; Kayley Trotter; Adair Reidy; Rahman Rakhshanda; Drew Payne; Marjorie Jenkins; Fabio Grizzi; Lauren Littlefield; Maurizio Chiriva-Internati; Everardo Cobos
Journal:  Ann Transl Med       Date:  2014-09

Review 3.  Ocular adnexal marginal zone lymphoma of mucosa-associated lymphoid tissue.

Authors:  Dimitrios Kalogeropoulos; Alexandra Papoudou-Bai; Panagiotis Kanavaros; Chris Kalogeropoulos
Journal:  Clin Exp Med       Date:  2017-09-22       Impact factor: 3.984

Review 4.  [Lymphoma of the ocular adnexa].

Authors:  V Kakkassery; N Stübiger; I A Adamietz; I Tischoff; A Baraniskin; I M Wunderlich
Journal:  Ophthalmologe       Date:  2015-03       Impact factor: 1.059

5.  [Diagnostics and treatment of choroidal lymphoma].

Authors:  D Doycheva; M Zierhut; D Süsskind; K U Bartz-Schmidt; C Deuter
Journal:  Ophthalmologe       Date:  2015-03       Impact factor: 1.059

Review 6.  Conjunctival Lymphoma.

Authors:  Lindsay A McGrath; David A Ryan; Sunil K Warrier; Sarah E Coupland; William J Glasson
Journal:  Eye (Lond)       Date:  2022-07-26       Impact factor: 4.456

Review 7.  [Malignant lymphomas of the eye].

Authors:  F Fend; D Süsskind; C Deuter; S E Coupland
Journal:  Pathologe       Date:  2017-11       Impact factor: 1.011

8.  Immunohistochemical analysis indicates that the anatomical location of B-cell non-Hodgkin's lymphoma is determined by differentially expressed chemokine receptors, sphingosine-1-phosphate receptors and integrins.

Authors:  Stephen Middle; Sarah E Coupland; Azzam Taktak; Victoria Kidgell; Joseph R Slupsky; Andrew R Pettitt; Kathleen J Till
Journal:  Exp Hematol Oncol       Date:  2015-04-01

9.  Diagnostic efficacy of cell block method for vitreoretinal lymphoma.

Authors:  Satoru Kase; Kenichi Namba; Daiju Iwata; Kazuomi Mizuuchi; Nobuyoshi Kitaichi; Yoshiaki Tagawa; Hiromi Okada-Kanno; Yoshihiro Matsuno; Susumu Ishida
Journal:  Diagn Pathol       Date:  2016-03-17       Impact factor: 2.644

10.  A case of intravascular lymphoma diagnosed with a primary vitreoretinal lymphoma-like fundus lesion.

Authors:  Masaki Asakage; Kazuhiko Umazume; Hiroyuki Takoi; Daigo Akahane; Yasunori Ishibashi; Hiroshi Yamaguchi; Masahide Gondo; Hiroshi Goto
Journal:  J Ophthalmic Inflamm Infect       Date:  2021-12-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.